SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.480
-0.070 (-4.52%)
At close: Mar 28, 2025, 4:00 PM
1.516
+0.036 (2.45%)
Pre-market: Mar 31, 2025, 8:08 AM EDT
SABS's stock price has decreased by -64.93% in the past year and price targets may not have had time to catch up.
SAB Biotherapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$12.40
Upside
+737.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,589.19% | Jan 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +305.41% | Jan 29, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,589.19% | Nov 7, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +643.24% | Oct 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $12 | Buy | Reiterates | $12 | +710.81% | Sep 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,589.19% | Sep 9, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $12 | Buy | Initiates | $12 | +710.81% | Aug 28, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,589.19% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +305.41% | Aug 12, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +440.54% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +305.41% | May 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,589.19% | May 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +305.41% | Apr 16, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +1,589.19% | Apr 16, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $3 → $25 | Strong Buy | Maintains | $3 → $25 | +1,589.19% | Apr 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +305.41% | Apr 2, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.